12h agoMarketWatchBULLISH 63General
Archived explainer. For the current picture see today's RVTY page.
Why Is REVVITY INC (RVTY) Stock Up Today?
By the Top Tier Newswire AI Desk · September 16, 2026 at 12:10 AM ET · reviewed against 4 wire stories
REVVITY INC (RVTY) is up +9.11% in the latest session. Our newswire has captured 4 stories on RVTY across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
RVTY stock is up 9.11% today, closing at $140.19, setting a new 52-week high. The move follows the company's presentation at the 2026 Global Healthcare Conference and a series of analyst updates that have raised price targets and reinforced confidence in the firm's strategic direction. The stock's performance is also supported by broader market momentum and positive sentiment around the biotech sector.
What Happened
Revvity Inc. (RVTY) shares surged to a new 52-week high after the company presented at the 2026 Global Healthcare Conference on September 15. This event highlighted the firm’s strategic initiatives, including the recent acquisition of French biotech firm Human Cell Design, which positions Revvity for growth in the GLP-1 drug development space. Analyst activity has also contributed to the upward momentum, with UBS raising its price target to $140 and Keybanc lifting its target to $165, both maintaining positive outlooks. The stock’s performance was further amplified by broader market action, including a rise in 10-year yields and strong oil prices, which have driven risk-on sentiment across equities.
What The Data Shows
RVTY closed at $140.19, reaching a new 52-week high on the session. The stock has traded between $81.22 and $133.00 over the past year, with a current price-to-earnings ratio of 61.4 and a market cap of $13.9 billion. Revenue has grown by 4.1% in the trailing twelve months, supported by an 8.2% net margin. The stock has a beta of 1.09, indicating moderate volatility relative to the market. Volume has been elevated, though no unusual options activity was reported. Insiders have been net sellers recently, with one executive selling $9,000 in shares. Meanwhile, former President Donald J. Trump disclosed a recent purchase of $50,001 to $100,000 in RVTY stock in March.
What To Watch
The company is scheduled to present at the 2026 Global Healthcare Conference, which may offer further insights into its strategic direction. Investors should also monitor the breadth of analyst coverage and any upcoming corporate actions for additional signals.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
RVTY by the numbers
Last: $140.19Session: +9.11%Coverage: 4 stories / 3 sourcesAI sentiment: 60/100 (bullish)Mkt cap: $13.9BP/E: 61.452w: $81.22 to $133.00
The headlines behind the move
12h agoSeeking AlphaBULLISH 73General
Revvity extends gains with another 9% advance, sets new high
Revvity (RVTY) stock jumps ~9% to a new 52-week high.
17h agoCNBCNEUTRAL 50General
Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more
These are the stocks posting the largest moves midday.
17h agoSeeking AlphaBULLISH 55General
Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript
Revvity, Inc. (RVTY) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDTCompany ParticipantsStephen Willoughby - Senior VP of Investor...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on RVTY: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier RVTY move explainers: 2026-09-16 · 2026-09-15